http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6704824

Outgoing Links

Predicate Object
contentType Journal Article|Published Erratum
endingPage 17406
issn 1949-2553
issueIdentifier 10
pageRange 17406-17406
publicationName Oncotarget
startingPage 17406
bibliographicCitation Pan Y, Robertson G, Pedersen L, Lim E, Hernandez-Herrera A, Rowat AC, Patil SL, Chan CK, Wen Y, Zhang X, Basu-Roy U, Mansukhani A, Chu A, Sipahimalani P, Bowlby R, Brooks D, Thiessen N, Coarfa C, Ma Y, Moore RA, Schein JE, Mungall AJ, Liu J, Pecot CV, Sood AK, Jones SJ, Marra MA, Gunaratne PH. Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer. Oncotarget. 2017 Mar 07;8(10):17406. PMID: 28403581; PMCID: PMC5370050.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ecd0a2294f49ed0b3236df8bd9e1cbbb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_187ee79589a3f35ac61b01a0e363b6f6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71e552546e2cd80b968893e1f85fec88
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f82a9a104d1b5c731783a5cc12bd621
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0064a68702bf0ff8f2390e2121da98eb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db5a241aab1bda225ad6fd8a3228a18a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7d9b08904476d1bcf8fbbafe39c5830
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e1526ec87d75eb18732e22794a87ccd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dcd6215bf1247280e07ef2e1c654c417
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2526db0fbb903994430a957a4052d3a6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de41410d37073bb9400621789d167faa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdc07e87a0a0e4a7fdd7839899809d89
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_beb5039c6086e25f360f169ddfb7dd10
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c362f7de74c551733c4712cb24cc5ab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa40a56119f9d1641e0b3629b207c4c3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34d2f0baff3ae418f5adce441ec0bed8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77cd64d8041e99a59386c4707c05ae90
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0905-2742
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d16f0b73869b89f8d897a89c4aefe0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2c38c4da204e4d828018d11bab2415b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1020-3242
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67ae3dd2f1497f36f70997f381357f94
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d149a5df28b9de736b298c2cd8229096
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db24bb4d45d86693d1f58e6f44eea953
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bdf2026367a31e22086c38ab613d091
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2db5e9e41b6d215d7a5ee6eca69d1dce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41ae687038d9a5856a9d57fae898c578
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e9abc254043e584b82cc8aceec84458
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32782a01cd91a5c0e50b33191bb54a08
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_317eb7bb039519a56f234b9f91e57341
date 2017-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.18632/oncotarget.15921
https://pubmed.ncbi.nlm.nih.gov/PMC5370050
https://pubmed.ncbi.nlm.nih.gov/28403581
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803
https://portal.issn.org/resource/ISSN/1949-2553
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer

Total number of triples: 48.